Page last updated: 2024-10-21

phenytoin and Antiphospholipid Syndrome

phenytoin has been researched along with Antiphospholipid Syndrome in 1 studies

Antiphospholipid Syndrome: The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prabhu, PR1
Cherian, JV1
Varghese, SJ1
Revathy, MS1
Jayanthi, V1

Other Studies

1 other study available for phenytoin and Antiphospholipid Syndrome

ArticleYear
Seizure and prominent abdominal veins.
    Lancet (London, England), 2007, Oct-06, Volume: 370, Issue:9594

    Topics: Antibodies, Anticardiolipin; Anticonvulsants; Antiphospholipid Syndrome; Humans; Male; Middle Aged;

2007